Physician profile
Alexandre M Rosen
NPI 1689822413
$2,034.77
in general payments reported to CMS, 2019-2025
21 companies · $74.89 in 2025
The $74.89 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $112 · 2020: $41.60 · 2021: $21.34 · 2022: $130 · 2023: $217 · 2024: $1,438 · 2025: $74.89.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,390 · Food and Beverage: $340.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,389.90 |
| Food and Beverage | $339.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Procept Biorobotics Corporation | $1,411.70 | 2024-2025 | Aquabeam System |
| Janssen Pharmaceuticals, INC | $125.12 | 2022-2023 | Xarelto |
| Sumitomo Pharma America, INC. | $71.57 | 2023 | Gemtesa, Orgovyx |
| Impulse Dynamics (USA) INC. | $41.55 | 2024 | Optimizer |
| Novo Nordisk INC | $40.82 | 2019 | |
| Teleflex LLC | $39.25 | 2022 | |
| Ambu INC. | $39.21 | 2020-2025 | |
| Urovant Sciences INC | $34.47 | 2022 | |
| Astellas Pharma US INC | $26.81 | 2019 | |
| Mallinckrodt Hospital Products INC. | $21.34 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $21.28 | 2022 | |
| Blue Earth Diagnostics | $21.26 | 2019 | |
| Coloplast Corp | $20.70 | 2020 | |
| Merck Sharp & Dohme LLC | $19.09 | 2022 | |
| Axonics, INC. | $18.18 | 2023 | Axonics |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $17.95 | 2025 | Watchman Flx |
| Exact Sciences Corporation | $17.85 | 2023 | Cologuard Collection Kit |
| Resmed Corp | $16.83 | 2025 | |
| Pfizer INC. | $12.40 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $10.81 | 2019 | |
| Intuitive Surgical, INC. | $6.58 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexandre Rosen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.